UroGen Pharma Ltd. (URGN) Insider Trading
Over the last 3 months, URGN insiders made 0 open-market buys and 4 sales, a net sale of -$3.7M (SEC Form 4). Over the last 6 months, 52 institutions increased and 52 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
4
Net (3m)
-$3.7M
Insider trades by month Buys Sells
Nov
Feb
May
Jun
Jul
Aug
Context3-month price +56.8%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Robinson James A. Jr.director | Option | 2,000 | — |
| Aug 24, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 60,677 | $47.05 |
| Jul 10, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 10,000 | $40.00 |
| Jun 24, 2026 | Belldegrun Ariedirector | Grant | 20,000 | $34.99 |
| Jun 24, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 10,000 | $35.01 |
| Jun 24, 2026 | Wildman Daniel Georgedirector | Grant | 10,000 | $34.99 |
| Jun 24, 2026 | Wildman Daniel Georgedirector | Grant | 8,000 | — |
| Jun 24, 2026 | Robinson James A. Jr.director | Grant | 10,000 | $34.99 |
| Jun 24, 2026 | Robinson James A. Jr.director | Grant | 8,000 | — |
| Jun 24, 2026 | Holden Stuartdirector | Grant | 20,000 | $34.99 |
| Jun 24, 2026 | BUTITTA CYNTHIA Mdirector | Grant | 10,000 | $34.99 |
| Jun 24, 2026 | BUTITTA CYNTHIA Mdirector | Grant | 8,000 | — |
| Jun 24, 2026 | WEN LEANAdirector | Grant | 10,000 | $34.99 |
| Jun 24, 2026 | WEN LEANAdirector | Grant | 8,000 | — |
| Jun 9, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 5,222 | $27.30 |
| Jun 9, 2026 | Schoenberg Markofficer: Chief Medical Officer | Option | 10,000 | — |
| May 27, 2026 | Robinson James A. Jr.director | Option | 2,000 | — |
| May 11, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 10,000 | $30.00 |
| Feb 27, 2026 | Robinson James A. Jr.director | Option | 2,000 | — |
| Feb 19, 2026 | Barrett Elizabeth A.officer: Chief Executive Officer | Grant | 153,195 | — |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Sell | 2,654 | $19.69 |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Sell | 3,217 | $19.69 |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Option | 3,333 | — |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Grant | 32,609 | — |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Option | 6,667 | — |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Sell | 1,608 | $19.69 |
| Feb 11, 2026 | Smith Jason Drewofficer: General Counsel | Option | 5,500 | — |
| Feb 4, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 1,844 | $19.69 |
| Feb 4, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 1,843 | $19.69 |
| Feb 4, 2026 | Schoenberg Markofficer: Chief Medical Officer | Sell | 3,686 | $19.69 |
Source: URGN SEC Form 4 filings, latest Aug 28, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their URGN positions over the last 6 months (SEC Form 13F).
Increased
52
New positions
33
Reduced
52
Sold out
172
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| RTW INVESTMENTS, LP | Unchanged | 4.5M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2.8M | May 13, 2026 |
| TORONTO DOMINION BANK | New Position | 2.6M | May 15, 2026 |
| MORGAN STANLEY | Reduced | 2.6M | May 15, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | New Position | 2.2M | May 15, 2026 |
| JEFFERIES FINANCIAL GROUP INC. | Unchanged | 2.2M | May 8, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Reduced | 1.7M | May 15, 2026 |
| ACORN CAPITAL ADVISORS, LLC | Increased | 1.7M | May 15, 2026 |
| SG AMERICAS SECURITIES, LLC | Increased | 1.7M | Apr 16, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 1.6M | May 15, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | Reduced | 1.5M | May 14, 2026 |
| OPALEYE MANAGEMENT INC. | Increased | 1.4M | May 15, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | Increased | 1.3M | May 15, 2026 |
| MENORA MIVTACHIM HOLDINGS LTD. | Unchanged | 1.2M | May 14, 2026 |
| D. E. SHAW & CO., INC. | Increased | 1.0M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.